Biogen’s Global Clinical Operations (GCO) team based in Maidenhead consists of teams designing, planning and executing Phase I - IV clinical trials in Neurology and Immunology. These studies are conducted on both small molecules and monoclonal antibodies to serve disease areas with high unmet need.
Clinical trial teams are organised globally within Biogen, not regionally. Maidenhead based Operations staff such as Clinical Programme Leaders, Clinical Trial Managers and Co-ordinators routinely work closely with colleagues in Cambridge, (Massachusetts) and Biogen staff in countries around the globe to enable execution of our global clinical studies. Our expanding operational footprint places Biogen having Clinical Operations staff in more than 15 countries worldwide (ranging from North and South America, across Western, Central and Eastern Europe to India, Japan, China and Australasia). Our trial management experts in Maidenhead work alongside Outsourcing Specialists, Clinical Business Operations, Biostatistics and partner with GCP compliance team.